C07D 241/44
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
C07D241/44 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 707 US grants and 584 published applications in this corpus.
Search patents in C07D- Granted patents
- 707
- Published applications
- 584
- Assignees
- 409
- Inventors
- 2,345
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 2 | 0 |
| 1978 | 7 | 0 |
| 1979 | 7 | 0 |
| 1980 | 5 | 0 |
| 1981 | 13 | 0 |
| 1982 | 12 | 0 |
| 1983 | 6 | 0 |
| 1984 | 13 | 0 |
| 1985 | 12 | 0 |
| 1986 | 7 | 0 |
| 1987 | 10 | 0 |
| 1988 | 4 | 0 |
| 1989 | 14 | 0 |
| 1990 | 19 | 0 |
| 1991 | 6 | 0 |
| 1992 | 12 | 0 |
| 1993 | 24 | 0 |
| 1994 | 6 | 0 |
| 1995 | 6 | 0 |
| 1996 | 13 | 0 |
| 1997 | 23 | 0 |
| 1998 | 20 | 0 |
| 1999 | 13 | 0 |
| 2000 | 18 | 0 |
| 2001 | 15 | 3 |
| 2002 | 24 | 25 |
| 2003 | 20 | 32 |
| 2004 | 18 | 33 |
| 2005 | 15 | 22 |
| 2006 | 16 | 23 |
| 2007 | 12 | 17 |
| 2008 | 10 | 21 |
| 2009 | 16 | 18 |
| 2010 | 16 | 36 |
| 2011 | 12 | 25 |
| 2012 | 16 | 22 |
| 2013 | 23 | 21 |
| 2014 | 27 | 36 |
| 2015 | 23 | 36 |
| 2016 | 25 | 22 |
| 2017 | 27 | 21 |
| 2018 | 20 | 30 |
| 2019 | 19 | 19 |
| 2020 | 21 | 19 |
| 2021 | 14 | 15 |
| 2022 | 6 | 18 |
| 2023 | 5 | 16 |
| 2024 | 9 | 23 |
| 2025 | 7 | 17 |
| 2026 | 10 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Benzothiazole and quinoline derivatives and their use22 Sep 2026US 12,741,948 B2Shanghai Yao Yuan Biotechnology Co., Ltd.
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Anti-inflammatory carboxamide derivatives21 Jul 2026US 12,686,657 B2Biomedcode Hellas SA
- Compounds and compositions for eye treatments7 Jul 2026US 12,673,925 B2Avedro, Inc.
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- Method for Treating Phosphorus-Containing Wastewater Produced During Preparation of Sulfonamide Compound8 Oct 2026US 2026/0308035 A1Nanhai Beisha Pharmaceutical Co., Ltd.
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Nitrogen-containing hetreocycles for organic electroluminescent devices27 Aug 2026US 2026/0255779 A1Merck Patent GmbH
- Heterocyclic compound, organic light-emitting element comprising same, and composition for organic layer27 Aug 2026US 2026/0255871 A1Lt Materials Co., Ltd.
- Mir-124 inducer, and preparation method therefor and use thereof13 Aug 2026US 2026/0232662 A1Nanjing Synnocare Pharmaceutical Technology Co., Ltd.
Most cited
By later US patents
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases232US 6,180,632 B2Aventis Pharmaceuticals Products Inc. · 2001
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases219US 6,482,834 B2Aventis Pharmaceuticals Inc. · 2002
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases207US 6,245,760 B1Aventis Pharmaceuticals Products Inc. · 2001
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases189US 6,528,526 B1Aventis Pharmaceuticals Inc. · 2003
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56.sup.lck tyrosine kinases188US 6,159,978 AAventis Pharmaceuticals Product, Inc. · 2000